Benefits of a multidisciplinary approach when optimizing current and integrating new heart failure treatments for improved outcomes: panel discussion.
Topic:
Drug therapy, other
Speaker:
Professor F. Ruschitzka (Zurich, CH)
Professor R. Hobbs (Oxford, GB)
Professor T. Jaarsma (Linkoping, SE)
Doctor J. Riley (London, GB)
Professor B. Pieske (Berlin, DE)
Doctor M. Senni (Bergamo, IT)
Sponsored by Novartis Pharma AG
Event:
HEART FAILURE 2016
Congress Presentation
About the speakers
Professor Frank Ruschitzka
University Heart Center, Zurich (Switzerland)
83
presentations
9
followers
Professor Richard Hobbs
Oxford (United Kingdom of Great Britain & Northern Ireland)
8
presentations
0
follower
Professor Tiny Jaarsma
Linkoping University, Linkoping (Sweden)
30
presentations
1
follower
Doctor Jillian Riley
Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
9
presentations
0
follower
Professor Burkert Pieske
Charite University Hospital, Berlin (Germany)
50
presentations
2
followers
Doctor Michele Senni
Papa Giovanni XXIII Hospital, Bergamo (Italy)
37
presentations
0
follower
4 more presentations in this session
Access the full session
About the event
ESC 365 is supported by
